Resultados de búsqueda - First Line

Facility-Level Medical Oncology Specialist Availability and First-Line Time to Treatment Failure in Lung Cancer: A Nationwide C-CAT Registry Analysis. por Kajiura, Shinya, Satake, Hironaga, Hayashi, Ryuji, Yoshino, Takayuki

Ver este registro en EBSCOhost

Facility-Level Availability of Japanese Society of Medical Oncology Specialists and Recorded First-Line Treatment-Process Duration in Pancreatic Cancer: A Nationwide Center for Can... por Kajiura, Shinya, Satake, Hironaga, Nakamura, Naohiko, Hayashi, Ryuji

Ver este registro en EBSCOhost

Cost-Effectiveness of First-Line Immunochemotherapy Versus BRAF Plus MEK Inhibitors in BRAF V600E -Mutated Metastatic Lung Cancer. por Chen, Chian-Wei, Tsai, Jui-Hung, Tsai, Sheng-Han, Chen, Li-Jun, Yang, Szu-Chun

Ver este registro en EBSCOhost

Evolving First-Line Endocrine Therapy in HR+/HER2− Metastatic Breast Cancer: CDK4/6 Inhibition, Biomarker-Guided Strategies and Emerging Therapeutic Paradigms. por Abdel-Razeq, Hikmat, Sharaf, Baha

Ver este registro en EBSCOhost

Claudin 18.2 Expression and Outcomes of First-Line Chemoimmunotherapy in HER2-Negative Gastric or Gastroesophageal Junction Cancer: A Single-Center Retrospective Study. por Bao, Run, Qin, Jing, Zhang, Rong, Xu, Zhuo, Liu, Jiahao, Shen, Jiaofeng, Zhang, Shunji, Zhang, Yusong, Zhu, Hong, Huang, Chunyan, Lu, Yan, Liu, Tianhua, Pu, Wangyang

Ver este registro en EBSCOhost

The Prognostic Significance of EGFR Adjusted Variant Allele Frequency on First-Line Osimertinib Efficacy in Advanced EGFR-Mutant NSCLC. por Phillips, William J., Leong, Russell, Yeung, Benjamin, Al Lawati, Ahmed, Camidge, D. Ross, Lo, Bryan, Wheatley-Price, Paul

Ver este registro en EBSCOhost

First-Line Bruton's Tyrosine Kinase Inhibitor-Based Regimens for Mantle Cell Lymphoma. por Puckrin, Robert, Villa, Diego, Fleury, Isabelle, Larouche, Jean-François, Kuruvilla, John

Ver este registro en EBSCOhost

Real-World Outcomes of First-Line Cetuximab and Platinum-Based Chemotherapy in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: A Multicenter Observational Study... por Rakušić, Zoran, Bišof, Vesna, Vušković, Sanja, Kotromanović, Zdenka, Erić, Suzana, Viculin, Jelena, Vazdar, Ljubica, Prpić, Marin, Kust, Davor, Vučinić, Damir

Ver este registro en EBSCOhost

"Trust, Responsibility, and Making a Difference": Qualitative Insights into Why First-Line Managers in Healthcare Remain in Their Role. por Svanström, Jonas, Lindberg, Magnus, Skytt, Bernice, Lindberg, Maria

Ver este registro en EBSCOhost

Overcoming Acquired MET-Driven Resistance to First-Line Lorlatinib: Successful Combination of Lorlatinib and Envafolimab in an ALK-Positive NSCLC Patient with Ultra-High PD-L1 Expr... por Ding, Lu, Nuersulitan, Reyizha, Wang, Jingjing, Chen, Hanxiao, Zhuo, Minglei

Ver este registro en EBSCOhost

First-Line Pembrolizumab Monotherapy for Advanced Non-Small Cell Lung Cancer: A Multicenter Real-World Study from Vietnam. por Pham, Thi Huong, Pham, Cam Phuong, Nguyen, Thi Thu Huong, Nguyen, Khanh Toan

Ver este registro en EBSCOhost

Initial Low-Dose Dacomitinib for First-Line Treatment of Patients With EGFR Exon 21-Mutated Non-Small-Cell Lung Cancer. por Liu, Ke-Jun, Huang, Lin-Xuan, Jiang, Guan-Ming, Guo, Ning-Ning, Tan, Qing-Lin, Cai, Yan-Min, Chen, Shi-Yuan, Du, Wei, Fang, Nian-Xin, Jia, Jun

Ver este registro en EBSCOhost

Clinical Outcomes and Immune-Related Adverse Events in Metastatic Non-Squamous NSCLC Treated with First-Line Pembrolizumab–Chemotherapy: A Real-World Study from Serbia. por Bojić, Zlatan, Marković, Filip, Kontić, Milica

Ver este registro en EBSCOhost

Real-World Utilization of Palbociclib as First-Line Treatment for Canadian HR+/HER2− Women with Metastatic Breast Cancer: Results from PALCAN Study. por Rayson, Daniel, Bertin, Jonathan, Lemelin, Maxim, Tong, Madeline, Ng, Ryan, Ding, Philip, Cheung, Winson Y., Sharma, Arushi, On, Phu Vinh, Feugère, Guillaume, Lupichuk, Sasha

Ver este registro en EBSCOhost

Evidence-to-Decision Framework to Prioritize PD-1 and PD-L1 Immune Checkpoint Inhibitors for the WHO Model List of Essential Medicines to Treat Adults with Solid Tumors in the Pall... por Bartoszko, Jessica, Schroer, Julia, Cappello, Bernadette, Iyengar, Swathi, Goldkuhle, Marius, Skoetz, Nicole, Csenar, Mario, Moja, Lorenzo

Ver este registro en EBSCOhost

Comparative Efficacy and Safety of First-Line Immune Checkpoint Inhibitors Plus Chemotherapy with or Without Bevacizumab in Advanced Non-Squamous Non-Small Cell Lung Carcinoma. por Chen, Ping, Wang, Mengchi, Peng, Siyan, Zhu, Honglin, Wang, Yanming, Wan, Zixuan, Yang, Xuan, Yu, Zhixin, Zhou, Yixin

Ver este registro en EBSCOhost

First-Line Modified FOLFIRINOX in Metastatic Pancreatic Cancer: Real-World Outcomes and Prognostic Factors From a Vietnamese Cohort. por Nguyen, Huy Van, Dinh, Phuong Thi, Tran, Thang, Hoang, Cuc Thi

Ver este registro en EBSCOhost

Prognostic Value of Baseline Systemic Immune-Inflammation Index in Advanced Intrahepatic Cholangiocarcinoma Treated with First-Line Gemcitabine–Cisplatin Plus PD-L1 Inhibitor: A Si... por Wu, Shuan, Xu, Jiawei, Li, Yan, Yu, Decai

Ver este registro en EBSCOhost

A Podcast on Real-World Evidence with Avelumab First-Line Maintenance and Treatment Sequencing in Locally Advanced or Metastatic Urothelial Carcinoma. por Grivas, Petros, Moon, Helen H.

Ver este registro en EBSCOhost

Expanded span of control, leadership and management performance, work-related stress, and job satisfaction among first-line managers: A repeated cross-sectional study. por Svanström, Jonas, Skytt, Bernice, Lindberg, Maria, Lindberg, Magnus

Ver este registro en EBSCOhost